Join the Bullous Pemphigoid group to help and get support from people like you.
Bullous Pemphigoid News
Dupixent (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
TARRYTOWN, N.Y. and PARIS, June 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dup...
Further information
Related drug support groups
prednisone, doxycycline, methotrexate, Dupixent, erythromycin, prednisolone, etanercept, rituximab, tetracycline, dupilumab